IMR Press / CEOG / Volume 45 / Issue 2 / DOI: 10.12891/ceog3851.2018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Editorial Article
The pros and cons of the requirement by the Society for Assisted Reproductive Technology (SART) for their members who perform in vitro fertilization and related procedures to report their pregnancy rates to the center for disease control
J.H. Check1, 2, *
Show Less
1 Cooper Medical School of Rowan University, Camden, NJ, USA
2 Cooper Institute for Reproductive and Hormonal Disorders, P.C., Mt. Laurel, NJ, USA
Clin. Exp. Obstet. Gynecol. 2018, 45(2), 155–158; https://doi.org/10.12891/ceog3851.2018
Published: 10 April 2018
Abstract

Purpose: To present pros and cons of the requirement of in vitro fertilization (IVF) centers, to record their statistics, and make them public. Materials and Methods: Various tricks are presented as to how some IVF centers can “pad” their pregnancy rates. Results: Some of these “tricks” include not trying as hard with the patients’ own oocytes but steering them into donor oocyte programs because, though they could eventually get pregnant with their own eggs, it could be at the detriment of the given IVF center's pregnancy rates, which in turn, could be “bad for business”. Conclusions: Published statistics help a patient to choose an experienced center with a good pregnancy rate, but the consumer should not necessarily equate the IVF center with the highest pregnancy rates as the best center for their problem.
Keywords
Diminished oocyte reserve
Blastocysts transfer
Pre-implantation genetic diagnosis
Embryo stockpiling
Donor oocyte
Share
Back to top